This approach effectively combined photothermal therapy with anti-PD-L1 immunotherapy, inhibiting tumor recurrence and metastasis, reprogramming the tumor microenvironment, and enhancing the antitumor immune response(Figure 8) [6]. This evidence concerns the gene CD274 and neoplasm.